Skip to content

Penumbra PEN Investing Cash Flow

Investing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.04B-250%
Stryker logo
StrykerSYK
-$185M+95.5%
Medtronic logo
MedtronicMDT
-$917M-87.1%
Boston Scientific logo
Boston ScientificBSX
-$591M-18.2%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's investing cash flow?
Penumbra (PEN) reported investing cash flow of -$30.63M in Q1 2026.
How has Penumbra's investing cash flow changed year-over-year?
Penumbra's investing cash flow decreased by 6002.2% year-over-year, from -$502K to -$30.63M.
What is the long-term trend for Penumbra's investing cash flow?
Over 2 years (2021 to 2025), Penumbra's investing cash flow has grown at a 331.4% compound annual growth rate (CAGR), from -$21.74M to -$404.59M.
What does investing cash flow mean?
The total net cash spent on or generated from investments in long-term assets and financial securities.
How do you interpret investing cash flow?
Negative values are typical for growth-stage medical device firms investing in manufacturing and R&D infrastructure.
How does investing cash flow compare across companies?
Highly dependent on the company's current investment cycle and M&A activity compared to industry peers.